Polycystic Ovarian Syndrome

pcos

Polycystic Ovary Syndrome (PCOS) is a hormonal condition characterized by ovulatory dysfunction and androgen excess. It may also be associated with insulin resistance in many cases, affecting menstrual regularity, fertility, and metabolic regulation.

Common symptoms of PCOS

  • Irregular menstrual cycles due to inconsistent or absent ovulation
  • Excess facial or body hair growth (hirsutism)
  • Thinning hair on scalp (androgen-related pattern hair loss)
  • Acne, often along jawline or lower face
  • Weight gain, often with central fat distribution
  • Skin darkening in folds (e.g. neck, groin, under breasts)
  • Fertility challenges related to ovulatory dysfunction

Clinical variability in PCOS

PCOS presents with variable symptom patterns depending on underlying physiological drivers.

Not all individuals experience insulin resistance or ovarian cysts.

Hormonal disruption may originate from ovarian, adrenal, or metabolic pathways, and may be influenced by stress-related hormonal regulation patterns.

Investigation and Assessment

Assessment focuses on identifying hormonal, metabolic, and reproductive patterns contributing to PCOS presentation.

This helps clarify both the presentation and underlying drivers of PCOS in each individual case.

Testing may include:

  • FSH (day 3 of cycle, if cycling)
  • LH (day 3 of cycle, if cycling)
  • Estradiol (day 11-13 of a 28-day cycle, if cycling)
  • Progesterone (day 21-28 of a 28-day cycle, or 7 days post-ovulation if cycling)
  • Cortisol
  • Free Testosterone, Total testosterone
  • Prolactin
  • DHT – Dihydrotestosterone
  • SHBG – Sex Hormone Binding Globulin
  • HbA1C, fasting glucose, fasting insulin
  • DHEA
  • Ferritin
  • TSH, free T4, free T3
  • 25-hydroxy Vitamin D

More comprehensive testing (e.g. DUTCH test) may be used when additional insight into hormone metabolism and downstream metabolites is clinically helpful.

Management of PCOS

Management is guided by identifying the primary physiological drivers of PCOS symptoms.

Interventions may vary depending on whether primary drivers involve:

  • Ovulatory dysfunction
  • Androgen excess
  • Insulin resistance or metabolic dysfunction
  • Stress-related hormonal regulation patterns

Inflammatory and metabolic contributors are considered in all cases as part of baseline clinical assessment.

Treatment may involve dietary and lifestyle interventions, targeted supplementation, and ongoing monitoring based on clinical response.

Adjunctive therapies such as acupuncture, injection therapies, or IV nutrient therapy may be considered when clinically appropriate.